Daiichi Sankyo

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

She has also served in various positions for Daiichi Sankyo, Novartis, Eli Lilly and GlaxoSmithKline.

Vernalis accepts £33m takeover offer from Ligand Pharma

If the deal goes through, Ligand will inherit a portfolio of more than eight fully-funded partnered programmes focused around central nervous system, oncology and inflammation, including collaborations with Servier, Daiichi ... Sankyo, Lundbeck, Asahi

Daiichi gets breakthrough status for pre-NDA leukaemia drug

Quizartinib could have an advantage over rival drug Rydapt. Daiichi Sankyo is gearing up to file its acute myeloid leukaemia (AML) treatment quizartinib in the US, and could now get a ... After a year, survival was 26% with Daiichi Sankyo’s drug and 20%

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

Meanwhile Daiichi Sankyo is now gearing up to file its acute myeloid leukaemia (AML) treatment quizartinib after it showed extended survival in a phase 3 trial of patients with FLT2-ITD

Abeona Therapeutics appoints new additions to board of directors

Van Duyne, on the other hand, has previously held executive-level business development positions, which led him to serve as global head of business development for Daiichi Sankyo.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]